The 411 on a GLP-1

What T2D Therapy Have You Considered for Your Patients After Metformin?

How common is treatment inertia in the treatment of adult patients with T2D and what can be done about it? Join a multidisciplinary panel including Jim Gavin, MD, PhD; Steve Vacalis, DO; and Jodi Strong, DNP, CDE, BC-ADM, CPT as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.


This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.


James gavin

James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc. 

Atlanta, Georgia


jodi strong

Jodi Strong, DNP, CDCES, BC-ADM, CPT
Aspirus Medical Group

Stevens Point, Wisconsin


Steve Vacalis

Steve Vacalis, DO
Senior Lead Physician
CaroMont Family Medicine, CaroMont Regional Medical Center
Gastonia, North Carolina


Submit Feedback